Sign in or register to see full information and data.

Studies / CAVD 315


Study information

Grant Affiliation:Weiss: Protection by Neutralizing Antibodies
Strategy:Combo: DNA, protein & vector vaccines
Study Type:Pre-Clinical Non-NHP
Stage:Assays Completed
Study Start Date:2010-03-23
Study Made Public:2011-08-08


Priming for neutralising antibody responses in rabbits by electroporation of HIV env and gag DNA, boosting with virus-like particles.


CAVD 315 is a preclinical rabbit study investigating several prime-boost regimens in which plasmid DNA (HIV gag) or env gp160 and gp41 proteins were boosted with mimotope from the env gp41 region with cholera toxin B as an immune stimulator.


CFA IFA CN54env-gp140 CN54env-gp145 CTM-2F5 R2env-gp140 VLP-CTB VLP-CTB mimotope VLP-GAG VLP-R2 pCDNA-R2 pCDNA-gag

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.